We are studying a new drug for patients with triple-negative breast cancer and brain metastases to see if it can help shrink tumors and improve survival. The trial also examines safety and quality of life for participants.
Health conditions and diseases that the clinical trial is designed to study and treat.
Triple negative breast cancer (TNBC) is a type of breast cancer that does not have any of the three common receptors (estrogen, progesterone, and HER2) that are typically targeted in other breast cancer treatments. This makes it more challenging to treat, but there are ongoing clinical trials exploring new therapies.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.